409 related articles for article (PubMed ID: 25668361)
1. Virtual screening using combinatorial cyclic peptide libraries reveals protein interfaces readily targetable by cyclic peptides.
Duffy FJ; O'Donovan D; Devocelle M; Moran N; O'Connell DJ; Shields DC
J Chem Inf Model; 2015 Mar; 55(3):600-13. PubMed ID: 25668361
[TBL] [Abstract][Full Text] [Related]
2. Computational approaches to developing short cyclic peptide modulators of protein-protein interactions.
Duffy FJ; Devocelle M; Shields DC
Methods Mol Biol; 2015; 1268():241-71. PubMed ID: 25555728
[TBL] [Abstract][Full Text] [Related]
3. Computational Opportunities and Challenges in Finding Cyclic Peptide Modulators of Protein-Protein Interactions.
Duffy F; Maheshwari N; Buchete NV; Shields D
Methods Mol Biol; 2019; 2001():73-95. PubMed ID: 31134568
[TBL] [Abstract][Full Text] [Related]
4. Genetically Encoded Cyclic Peptide Libraries: From Hit to Lead and Beyond.
Valentine J; Tavassoli A
Methods Enzymol; 2018; 610():117-134. PubMed ID: 30390796
[TBL] [Abstract][Full Text] [Related]
5. Screening combinatorial libraries of cyclic peptides using the yeast two-hybrid assay.
Barreto K; Geyer CR
Methods Mol Biol; 2014; 1163():273-309. PubMed ID: 24841315
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein-Protein Interactions.
Krüger DM; Glas A; Bier D; Pospiech N; Wallraven K; Dietrich L; Ottmann C; Koch O; Hennig S; Grossmann TN
J Med Chem; 2017 Nov; 60(21):8982-8988. PubMed ID: 29028171
[TBL] [Abstract][Full Text] [Related]
7. Discovery of small peptide antagonists of PED/PEA15-D4α interaction from simplified combinatorial libraries.
Scognamiglio PL; Doti N; Grieco P; Pedone C; Ruvo M; Marasco D
Chem Biol Drug Des; 2011 May; 77(5):319-27. PubMed ID: 21294846
[TBL] [Abstract][Full Text] [Related]
8. High-throughput sequence determination of cyclic peptide library members by partial Edman degradation/mass spectrometry.
Joo SH; Xiao Q; Ling Y; Gopishetty B; Pei D
J Am Chem Soc; 2006 Oct; 128(39):13000-9. PubMed ID: 17002397
[TBL] [Abstract][Full Text] [Related]
9. Discovery and structural characterization of a phospholamban-binding cyclic peptide and design of novel inhibitors of phospholamban.
Tilgmann C; Pollesello P; Ovaska M; Kaivola J; Pystynen J; Tiainen E; Yliperttula M; Annila A; Levijoki J
Chem Biol Drug Des; 2013 Apr; 81(4):463-73. PubMed ID: 22578098
[TBL] [Abstract][Full Text] [Related]
10. Thioether analogues of disulfide-bridged cyclic peptides targeting death receptor 5: conformational analysis, dimerisation and consequences for receptor activation.
Pulka-Ziach K; Pavet V; Chekkat N; Estieu-Gionnet K; Rohac R; Lechner MC; Smulski CR; Zeder-Lutz G; Altschuh D; Gronemeyer H; Fournel S; Odaert B; Guichard G
Chembiochem; 2015 Jan; 16(2):293-301. PubMed ID: 25487639
[TBL] [Abstract][Full Text] [Related]
11. Geometric diversity through permutation of backbone configuration in cyclic peptide libraries.
Perlman ZE; Bock JE; Peterson JR; Lokey RS
Bioorg Med Chem Lett; 2005 Dec; 15(23):5329-34. PubMed ID: 16213707
[TBL] [Abstract][Full Text] [Related]
12. Constraining cyclic peptides to mimic protein structure motifs.
Hill TA; Shepherd NE; Diness F; Fairlie DP
Angew Chem Int Ed Engl; 2014 Nov; 53(48):13020-41. PubMed ID: 25287434
[TBL] [Abstract][Full Text] [Related]
13. Novel alpha-glucosidase inhibitors identified using multiple cyclic peptide combinatorial libraries.
Eichler J; Lucka AW; Pinilla C; Houghten RA
Mol Divers; 1996 Aug; 1(4):233-40. PubMed ID: 9237214
[TBL] [Abstract][Full Text] [Related]
14. Scaffolded multiple cyclic peptide libraries for protein mimics by native chemical ligation.
van de Langemheen H; van Hoeke M; Quarles van Ufford HC; Kruijtzer JA; Liskamp RM
Org Biomol Chem; 2014 Jul; 12(25):4471-8. PubMed ID: 24849139
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
[TBL] [Abstract][Full Text] [Related]
16. Disulfide-rich macrocyclic peptides as templates in drug design.
Northfield SE; Wang CK; Schroeder CI; Durek T; Kan MW; Swedberg JE; Craik DJ
Eur J Med Chem; 2014 Apr; 77():248-57. PubMed ID: 24650712
[TBL] [Abstract][Full Text] [Related]
17. Vicinal disulfide constrained cyclic peptidomimetics: a turn mimetic scaffold targeting the norepinephrine transporter.
Brust A; Wang CI; Daly NL; Kennerley J; Sadeghi M; Christie MJ; Lewis RJ; Mobli M; Alewood PF
Angew Chem Int Ed Engl; 2013 Nov; 52(46):12020-3. PubMed ID: 24115503
[No Abstract] [Full Text] [Related]
18. Bicyclic Peptides as Next-Generation Therapeutics.
Rhodes CA; Pei D
Chemistry; 2017 Sep; 23(52):12690-12703. PubMed ID: 28590540
[TBL] [Abstract][Full Text] [Related]
19. Cyclic peptidyl inhibitors of Grb2 and tensin SH2 domains identified from combinatorial libraries.
Zhang Y; Zhou S; Wavreille AS; DeWille J; Pei D
J Comb Chem; 2008; 10(2):247-55. PubMed ID: 18257540
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Synthesis and Identification of Cyclic Peptides for Bioapplications.
Ong YS; Gao L; Kalesh KA; Yu Z; Wang J; Liu C; Li Y; Sun H; Lee SS
Curr Top Med Chem; 2017; 17(20):2302-2318. PubMed ID: 28240181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
